The development of pharmaceutical tablets is fraught with challenges that span from design complexity to production scalability, significantly impacting the industry’s agility and cost-effectiveness. Traditional methods often lead to prolonged development cycles, high production costs due to inefficient design iterations, and suboptimal patient compliance due to overlooked usability factors.
These issues are exacerbated in an era where rapid market entry and patient-centric design are not just desired but demanded. Thus, there’s a pressing need in the industry for innovative technologies that can streamline this process, reduce costs and enhance product quality.
Advancements in predictive tablet design software, with a focus on digitalization and enhanced collaboration, offer a transformative solution to these longstanding issues.
By integrating AI for real-time design optimization, these tools can prevent potential manufacturing defects before they occur, tailor designs for patient usability, and incorporate features for seamless collaboration across departments and with external stakeholders. This digital leap not only accelerates the development cycle but also significantly cuts down on the financial and time costs associated with traditional pharmaceutical tablet development, promising a more efficient, cost-effective and patient-focused future.
Manufacturing Issues
During tablet manufacturing, issues like sticking (tablet material adhering to tooling), picking (material sticking in engravings), and capping (separation of the top or bottom of the tablet) can arise. These problems are often caused by poor formulation or improper tablet design, and they can result in significant production delays.
A pivotal issue exacerbating manufacturing defects in tablet production stems from the inadequate transfer of crucial design information to the tablet designer. When the intricate details of a tablet’s design, such as its geometric intricacies or specific material behaviors, are not fully or accurately relayed, it can lead to suboptimal or even flawed design requirements. This gap can cause the product to face significant hurdles during scale up or fail in delivering the intended therapeutic benefits. For example, the lack of clear communication regarding the tablet’s curvature or edge design might result in compression problems like sticking or capping, which are avoidable if these elements are properly accounted for during the initial design phases.
Furthermore, without detailed data on how different formulations interact with the tooling materials (which might be available but not shared), manufacturers run the risk of unexpected reactions during large-scale production runs, leading to wasted batches, downtime for machine adjustments, or even equipment damage. This discontinuity in information not only hampers the production process but also increases costs due to material wastage and extended production timelines, highlighting the need for a seamless transfer of comprehensive design knowledge to the manufacturing floor.
Advanced tablet design software tackles manufacturing challenges by integrating an AI-powered design engine. This technology actively suggests design adjustments to mitigate issues like sticking, picking and capping starting from the initial design phase. By utilizing design indexes, the software guides users towards optimal tablet configurations that are mindful of manufacturability, ensuring that critical aspects such as tablet hardness, curvature and material interactions are thoroughly considered upfront.
Moreover, this software engages users with strategic questions that influence the overall tablet design, ensuring all relevant factors — from material properties to geometric specifics — are addressed early in the process. This forward- thinking methodology not only minimizes errors through effective information transfer but also aligns design objectives with production realities, thereby reducing production delays, enhancing product quality and minimizing waste and costs.
Disjointed Design and Development Processes
Tablet design often involves collaboration among various stakeholders, such as marketing teams, formulation experts, coating companies, packaging suppliers and tooling manufacturers. Traditionally, this process is managed through emails, meetings and spreadsheets to develop an initial design, which can be difficult to track. The reliance on these fragmented tools often results in communication breakdowns and version control issues, leading to delays, costly revisions and inefficiencies. Effective coordination is vital to streamline the process and reduce time-to-market.
Additionally, each tablet design is currently produced by a design engineer who is not always provided with the details needed to make a robust design. This is largely inherent because this process introduces multiple people across different companies and departments to produce a single tablet design. This directly institutes a delay in the process and has several opportunities for miscommunication and high potential for error due to loss of information along the value chain. Considering these factors, one can conclude that this process is extremely susceptible to delays and iterations.
Furthermore, this process typically relies on 2D drawings to visualize the customer-facing product. However, 2D representations are limited in their ability to convey critical aspects such as physical size, shape and contour. Without a tangible way to connect these designs to real-world objects, teams may struggle to fully understand and refine the tablet’s geometry, potentially compromising the accuracy and effectiveness of the final product.
In summary, inefficiencies in traditional tablet design not only cause delays but also escalate development costs. Miscommunications and iterative design processes due to inadequate coordination tools can lead to budget overruns, making it crucial to address these financial aspects to underline the urgency for more streamlined design solutions.
Modern tablet design software revolutionizes collaboration by integrating an AI-driven platform with a virtual reality (VR) component, fundamentally altering how teams engage with the design process. By consolidating all revisions within this platform, it eliminates the chaos of traditional communication methods like emails and spreadsheets. The VR feature enables stakeholders, ranging from scientists to marketers, to enter a common virtual space where they can visualize, handle and discuss designs in three dimensions. This immersive approach provides a tactile understanding of the tablet’s size, shape, and texture, surpassing the limitations of 2D representations.
This collaborative environment not only unifies design vision but also speeds up decision-making processes through real- time interaction and adjustments, drastically cutting down on misunderstandings and iterative designs. Consequently, today’s design software not only streamlines the design workflow but also fosters closer collaboration among stakeholders, enhancing efficiency, reducing time-to-market and minimizing unnecessary expenses through an interactive and cohesive design experience.
Patient-Centric Concerns
The pharmaceutical industry invests heavily in the research and development of tablets to create products that can endure the rigors of various production scales, from small experimental batches to full-scale manufacturing. Despite this rigorous process, the focus on physical robustness often overshadows essential patient-centered design considerations. Elements such as the tablet’s dimensions, form, and external coating play a pivotal role in its usability, particularly for vulnerable patient demographics. For instance, the elderly or individuals with swallowing difficulties (dysphagia) might struggle with tablets that are too large or awkwardly shaped, leading to potential non-compliance with medication regimens. This neglect of ergonomic design principles can inadvertently obstruct the path from drug development to effective treatment administration.
Moreover, the visual and tactile appeal of a tablet, often determined by its coating, color and curvature, plays a significant role in patient perception and acceptance. The coating of a tablet isn’t merely for taste or protection; it’s also about creating a product that looks and feels right, influencing a patient’s psychological response to their medication. A tablet’s color can affect perceived efficacy, with certain colors associated with specific effects or calming qualities, potentially impacting patient compliance. Similarly, the curvature or shape of a tablet contributes to how easily it’s accepted visually and physically. A design that appears too clinical or uninviting might deter patients, even subconsciously, from adhering to their treatment plan.
The aesthetic qualities of pharmaceutical tablets, therefore, carry weight beyond mere appearance; they are integral to the overall therapeutic experience. A well-considered tablet design, with an appealing coating, an inviting color and a comfortable curvature, can play a crucial role in reducing the stigma or fear associated with taking medication, especially in long-term treatments or among children. This aspect of design can significantly enhance the user experience, making the act of taking medication less daunting or even pleasant, which in turn can foster greater adherence to medical advice.
Therefore, integrating patient-centric design into the earliest stages of tablet formulation is more than a matter of patient comfort; it’s an essential aspect of pharmaceutical efficacy. By prioritizing these factors, drug developers can enhance patient compliance, thereby ensuring that the therapeutic benefits of medications are fully realized. This approach requires a shift in how pharmaceutical companies think about drug design, moving from a purely chemical or biological focus to one that also embraces human factors engineering. In doing so, the industry not only improves health outcomes but also aligns product development with the actual needs and experiences of its end users, ultimately contributing to better public health outcomes.
Advanced tablet design software aids in maintaining a patient-centric approach by incorporating features like a ‘swallowability index,’ which quantitatively guides designers to create tablets optimized for ingestion, especially vital for groups such as the elderly or individuals with dysphagia.
Beyond just form and size, the software’s 3D modeling capabilities integrate considerations of color and texture, allowing designers to refine the tablet’s appearance and feel. This ensures aesthetics complement functionality, enhancing the overall patient experience.
Furthermore, the software utilizes virtual reality technology to connect digital designs with physical realities. By enabling users to compare a tablet’s dimensions against familiar items like coins in a VR setting, it offers an intuitive grasp of the tablet’s actual size. This tool is crucial for ensuring that the design, while appearing practical in a virtual space, is also user-friendly and comfortable in real-world applications, thereby bridging the gap between design concept and practical use.
Transforming the Tablet Landscape
Innovative tablet design software introduces a guided process for pharmaceutical companies, presenting a user-friendly interface that simplifies the design of tablets into an intuitive, interactive task. This platform queries users about their product’s goals, including its intended use, target audience and necessary formulation details. Utilizing AI, the software interprets these inputs to propose tablet designs that adhere to predefined parameters, instantly providing key metrics like volume, surface area and maximum compression force during the initial design stages.
This AI-centric methodology guarantees that the designs comply with manufacturing specifications while being tailored for patient usability. Its 3D design features allow for a comprehensive visual and tactile review of designs. This enables collaboration across departments such as R&D, marketing and external vendors, who can interactively refine and approve designs in real-time through the software’s sharing functions.
The peak of this design journey is the 3D immersive experience, where stakeholders can virtually manipulate the tablet, tweak settings and observe modifications instantly. This shared virtual space not only aligns the vision across all involved parties but also streamlines the progression from idea to market-ready product. By incorporating these advanced features, this software streamlines a design approach that is both technically accurate and collaboratively comprehensive, transforming the development landscape of pharmaceutical tablets.
About the Author
Michael Ruch began in mechanical engineering, earning an Associate of Applied Science degree with a focus on design engineering. Starting as a design engineer at Natoli Engineering, Michael advanced by developing software to automate, streamline and enhance tablet and tool design, leading to the creation of the latest TabletCAD version still in use today. Michael founded DevWorks Automation, specializing in design automation, large-scale engineering integrations, analytics and AI. In 2021, he co-founded TaBlitz, with a mission to revolutionize tablet design, emphasizing quality, efficiency and industry impact.
Publication Details
This article appeared in Tablets and Capsules Magazine:
Vol. 22, No. 5
November/December 2024
Pages: 11-14